Pharmacokinetics of Hydroxocobalamin in Smoke Inhalation Victims

References

• Baud F. J., Barriot P., Toffis V., et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991; 325: 1761–1766
   PubMed Web of Science ®Google Scholar
• Ballantyne B. Hydrogen cyanide as a product of combustion and a factor in morbidity and mortality from fires. Clinical and Experimental Toxicology of Cyanides, B. Ballantyne, T. Marrs. John Wright, BristolEngland 1987; 248–291
   Google Scholar
• Terrill J. B., Montgomery R. R., Reinhardt C. F. Toxic gases from fires. Science 1978; 200: 1343–1347
   PubMed Web of Science ®Google Scholar
• Graham D. L., Laman D., Theodore J., Robin E. D. Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med 1977; 137
   PubMed Web of Science ®Google Scholar
• Bismuth C., Cantineau J., Pontal P., et al. Priority de 1′oxygSnation dans l'intoxication cyanhydrique. J Toxicol Med 1984; 4: 107–121
   Google Scholar
• Mushett C. W., Kelley K. L., Boxer G. E., Rickards J. C. Antidotal efficacy of vitamin B12a (hydroxo-cobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952; 81: 234–237
   PubMed Web of Science ®Google Scholar
• Riou B., Baud F., Astier A., Barriot P., Lecarpentier Y. In vitro demonstration of antidotal efficacy of hydroxocobalamin in cyanide poisoning. J Neurosurg Anesthesiol 1990; 2: 296–304
   PubMed Web of Science ®Google Scholar
• Riou B., Baud F. J., Renaud C., Bismuth C. l'hydroxocobalamin. Les antidotes, F. Baud, P. Barriot, B. Riou. Masson, Paris 1992; 175–193
   Google Scholar
• Riou B., Berdeaux A., Pussard E., Giudicelli J. F. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intens Care Med 1993; 19: 26–32
   PubMed Web of Science ®Google Scholar
• Moore S. J., Norris J. C., Walsh D. A., Hume A. S. Antidotal use of methemoglobin forming cyanide antagonists in concurrent carbon monoxide/cyanide intoxication. J Pharmacol Exp Ther 1987; 242: 70–73
   PubMed Web of Science ®Google Scholar
• de La Coussaye J. E., Houeto P., Sandouk P., Levillain P., Sasine A., Riou B. Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol 1994; 6: 111–115
   PubMed Web of Science ®Google Scholar
• Yacoub M., Faure J., Morena H., Vincent M., Faure H. ‘Acute hydrocyanic acid intoxication. Current data on the metabolism of cyanide and treatment by hydroxocobalamin’. Eur J Toxicol Environ Hyg 1974; 7: 22–29
   PubMedGoogle Scholar
• Cottrell J. E., Casthely P., Brodie J. D., Patel K., Klein A., Turndorf H. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med 1978; 298: 809–811
   PubMed Web of Science ®Google Scholar
• Favier C., Baud F. J., Richter F., Imbert M. Tolerance of high doses of hydroxocobalamin (OHCO) in fire victims. Clin Intens Care 1993; 4: 69
   Google Scholar
• Auzepy P., Veissiere J., Deparis M. ‘Letter: Anaphylactic shock due to hydroxocobalamin’. Nouv Presse Med 1974; 3: 152
   PubMedGoogle Scholar
• Hillman R. S. Vitamin B12, folic acid, and the treatment of megaloblastic anemias. The Pharmacological Basis of Therapeutics, A. Gilman, L. Goodman, T. Rail, F. Murad. MacMillan, New York 1985; 1323–1337
   Google Scholar
• Shearman D. J., Calvert J. A., Ala F. A., Girdwood R. H. Renal excretion of hydroxocobalamin in man. Lancet 1965; 2: 1328–1330
   Web of Science ®Google Scholar
• Forsyth J. C., Mueller P. D., Becker C. E., et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy, and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31: 277–294
   PubMed Web of Science ®Google Scholar
• Houeto P., Buneaux F., Galliot-Guilley M., Baud F. J., Levillain P. Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning. J Anal Toxicol 1994; 18: 154–158
   PubMed Web of Science ®Google Scholar
• Rieders F. Cyanide. Methodology for Analytical Toxicology, I. Sunshine. CRC Press, Cleveland 1975; vol 1: 113–118
   Google Scholar
• Ballantyne B., Marrs T. C. Post-mortem features and criteria for the diagnosis of acute lethal cyanide poisoning. Clinical and Experimental Toxicology of Cyanides, B. Ballantyne, T. C. Marrs. John Wright, Bristol 1987; 217–247
   Google Scholar
• Moureu H., Chovin P., Truffert L., Lebbe J. Nouvelle micromethode pour la determination rapide et precise de l'oxycarbonemie par absorption selective dans l'infrarouge. Arch Mai Prof 1957; 18: 116–124
   PubMedGoogle Scholar
• Schwartz D. Methodes statistiques a I'usage des medecins et des biologistes. Flammarion, Paris 1963
   Google Scholar
• Evans C. L. Cobalt compounds as antidotes for hydrocyanic acid. Br J Pharmacol 1964; 23: 455–475
   PubMed Web of Science ®Google Scholar
• Astier A., Baud F. J. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high performance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanide poisoning. J Chromatogr B Biomed Appl 1995; 667: 129–135
   PubMedGoogle Scholar
• Dedrick R. L., Bischoff K. B., Zaharko D. S. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep 1970; 54: 95–101
   PubMedGoogle Scholar